Skip to content

Registry for Severe ROP and Treatment on Visual Outcomes

Study Registry for Severe Retinopathy and Treatment on Visual Outcomes of Premature Neonates

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01559571
Enrollment
324
Registered
2012-03-21
Start date
2012-05-31
Completion date
2020-05-15
Last updated
2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of Prematurity

Keywords

Retinopathy of Prematurity

Brief summary

The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.

Interventions

None listed

Sponsors

Pediatrix
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 7 Days
Healthy volunteers
Yes

Inclusion criteria

* Documentation of informed consent and authorization * Inborn and those admitted within 7 days of birth * Infant with a diagnosis of stage 2 ROP or higher * Site ability to plan close ophthalmological follow-up due to significant and persistent ROP * Parents must agree to report outcomes following each ophthalmological visit and overall outcomes for up to five (5) years of age * Ability to obtain follow-up data on outcomes if the child is transferred to another facility * No known major congenital anomalies

Exclusion criteria

* ROP stage 1 or less * Parents unwilling to participate in follow-up * Major congenital anomalies

Design outcomes

Primary

MeasureTime frame
Identification of visual acuity in subjects who were treated for ROPFive year follow-up

Secondary

MeasureTime frame
Recurrence of stage 3+ retinopathy of prematurity in one or both eyes in zone I or posterior zone II Recurrence of stage 3+ retinopathy of prematurity in one or both eyes in zone I or posterior zone IIFive year follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026